Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-26.7%
Return on assets-25.4%+4.1pp-29.4%
Return on invested capital-38.8%
Liquidity
Current ratio22.6×+2.0×20.6×-5.0×25.6×-9.7×35.3×+6.6×28.7×+14.2×
Quick ratio22.6×+2.0×20.6×-5.0×25.6×-9.7×35.3×+6.6×28.7×+14.2×
Cash ratio6.6×+1.5×5.1×-0.2×5.3×-0.3×5.6×-3.2×8.8×+5.1×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$6.42-16.4%$7.68+5.6%$7.27-99.9%$7,625.84+57,556%$13.23+131%
Valuation
Market capitalization$1.8B-1.7%$1.84B+41.4%$1.3B+83.6%$707.24M
Enterprise value$1.75B-2.1%$1.79B+42.2%$1.26B+86.1%$674.53M
Price / book6.3×+0.3×+1.9×+1.9×2.1×
Free cash flow yield-4%-0.4pp-3.6%+1.1pp-4.7%+4.3pp-9.1%
Earnings yield-4.7%-0.6pp-4.1%+1.3pp-5.4%+5.3pp-10.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Sionna Therapeutics, Inc. Common Stock's ratios come from?
Every ratio is computed from Sionna Therapeutics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.